Beyond Oral Agents & Insulin: New Frontiers in the Management of Diabetes and Cardiometabolic Risk A Primary Care Initiative.

Slides:



Advertisements
Similar presentations
NEW ORAL AGENTS IN DIABETES MANAGEMENT
Advertisements

Oral Hypoglycemic Drugs And Classifications
The efficacy of ‘Basal supported Oral Therapy ’ with ‘Sitagliptin’ in Japanese type 2 diabetes patients: Yoshihiko Suzuki HDC Atlas Clinic,
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach Update to a Position Statement of the American Diabetes Association.
Max Sanam.  Understand stages in animal virus replication  Compare and contrast the multiplication cycle of DNA and RNA-containing animal viruses 
John R. LaMontagne Memorial Symposium on Pandemic Influenza Research April 4-5, 2005 Institute of Medicine Working Group Four: Antivirals and Non-Specific.
Viruses and Prions Chapter Structure and Classification of Animal Viruses Structure DNA or RNA genome Double stranded (ds) or single stranded.
Introduction to viruses
Influenza Ieuan Davies. Signs and Symptoms Influenza is an acute, viral respiratory infection. Fever, chills, headache, aches and pains throughout the.
Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.
Lecture 29: Viruses 0.5 m.
Combination Therapy in Type 2 Diabetes
A. Respiration B. Producing energy C. Sexual reproduction D. Asexual reproduction.
P.S. Reichelderfer, PhD Harwood, Maryland WHIN Meeting, 2005 Fertility Regulation Update.
Chapter 19 Noncommunicable Diseases Next >> Click for: Lesson 4 Diabetes and Arthritis >> Main Menu >> Chapter 19 Assessment Teacher’s notes are available.
LONG TERM BENEFITS OF ORAL AGENTS
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 72 Glucocorticoids in Nonendocrine Disorders.
BELL WORK Do you know anyone with diabetes? What changes do you think you would need to make if your life if you had diabetes?
DIABETES MELLLITUS Strategies for Achieving Control in an Office Setting.
Copyright © 2003 Pearson Education, Inc. publishing as Benjamin Cummings Figure
Oral Hypoglycemic Drugs
Clinical Update in Type 2 Diabetes A Case Discussion Dr. Yancey R. Holmes, MD, FACE Ohio Valley Endocrinology.
Viruses Chapter 19. A Borrowed Life Virus: an infections particle incapable of replicating outside of a cell, which consists of an RNA or DNA genome enclosed.
Oral hypoglycemic drugs Prof. Mohammad Alhumayyd.
Oral hypoglycemic drugs Prof. Mohammad Alhumayyd.
cardio protection: Focus on
27 MAR 2007 Antiviral Drugs: An Overview Chris Brooks CHEM 5398 Medicinal Chemistry Prof. Buynak.
Branches of Microbiology Bacteriology Virology Mycology Parasitology Immunology Recombinant DNA technology.
Influenza A/H1N1 W. Rose H1N1 is a subtype of influenza type A Influenza types B and C also exist but less common, less infectious, and drift.
Current Therapy for Type II Diabetes. New ADA Guidelines- 4/20/12 Inzucchi, Diabetologia 4/20/12 SU most prominent- First, reading L to R Added back.
By: Dr. Fatima Makee AL-Hakak University of kerbala College of nursing.
Viruses. Virus A non living particle composed of a nucleic acid and a protein coat A non living particle composed of a nucleic acid and a protein coat.
Plasminogen-Activating Inhibitor-1 (PAI-1) High PAI-1 associated with: Obesity (especially visceral), possible fatty liver. 2,3,4 Inflammation and oxidative.
ANTIVIRAL AGENTS FOR THE PREVENTION AND TREATMENT ON INFLUENZA.
Identify the risk factors, diagnosis and prevalence of diabetes in the United States. Describe the function of the pancreas, the intestines and liver.
DH206: Pharmacology Chapter 21: Diabetes Mellitus Lisa Mayo, RDH, BSDH.
Viruses  What are they? and  What are they good for? (ebiomedia.com) (conference.eicar.org)
Oral hypoglycemic drugs
Antibiotics I.. Consequences of inappropriate antibiotic therapy Inappropriate antibiotic therapy can lead to increases in:Inappropriate antibiotic therapy.
Oral Diabetes Medications Carol Cordy, MD. Goals Understand how type 2 diabetes affects many organs and how this changes over the course of the illness.
{ Viral Replication  Virus: A biological particle composed of nucleic acid and protein  Intracellular Parasites: organism that must “live” inside a.
Dr. Sasan Zaeri (PharmD, PhD) Department of Pharmacology, BPUMS.
Guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association CHOICE OF AGENT AFTER INITIAL METFORMIN.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Glucocorticoids in Nonendocrine Diseases.
Copyright © 2015 by the American Osteopathic Association.
Good teaching is more a giving of right questions than a giving of right answers. – Josef Albers Viruses Chapter 19.
Glucose Homeostasis: In Health, Disease and With Treatment
VIRAL INFLUENZA.
GLP-1 Agonist:When to start ?
Virus Replication John Goulding, Imperial College London, UK
THE INFECTIOUS PROCESS FOR A VIRUS Despite their simplicity relative to bacteria, viruses still possess various biochemical targets for potential attack.
Dr. Sasan Zaeri (PharmD, PhD) Department of Pharmacology, BPUMS
Recommendation In people with clinical cardiovascular disease in whom glycemic targets are not met, a SGLT2 inhibitor with demonstrated cardiovascular.
Diabetic Dyslipidemia in Practice
Drugs for Diabetes Mellitus
Diabetes and Stroke.
Faster-Acting Insulins
המשותף לכל סוגי הסוכרת היפרגליקמיה כרונית.
Choice of Therapy MYTH: “Most Patients with ‘T2DM’ will eventually
Clinical Advances in Type 2 Diabetes and Cardiovascular Risk
Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use  David M. Kendall, MD, Robert M. Cuddihy, MD,
Pramlintide is a synthetic hormone given SC resembling human amylin effects It reduces the production of glucose by the liver by inhibiting the action.
Integrated Diabetes Care: How Can We Make the Best Use of New Technology?
Viruses Viruses – are segments of nucleic acids
Management of T1DM. Management of T1DM Route(S) Appearance Duration peak Onset (hours) Type of insulin   S.C, I.V(5) Clear صافي 3-6(2) 1-2(2)
Good teaching is more a giving of right questions than a giving of right answers. – Josef Albers Viruses Chapter 19.
Drugs for The Endocrine System
Viruses TEK 4C: Compare structures of viruses to cells, describe viral reproduction, and describe the role of viruses in causing diseases such as HIV and.
Guideline approach to drug therapy in newly diagnosed type 2 diabetic patients not at target. Guideline approach to drug therapy in newly diagnosed type.
Fig. 1. Antihyperglycemic therapy algorithm for adult patients with type 2 diabetes mellitus (T2DM). The algorithm stratifies the choice of medications.
Presentation transcript:

Beyond Oral Agents & Insulin: New Frontiers in the Management of Diabetes and Cardiometabolic Risk A Primary Care Initiative

Learning Objectives Describe the role of incretin physiology in diabetes and diabetes treatmentDescribe the role of incretin physiology in diabetes and diabetes treatment Explain the mechanism of action of the incretin mimeticsExplain the mechanism of action of the incretin mimetics Identify the role of glucose metabolism in addressing cardiometabolic riskIdentify the role of glucose metabolism in addressing cardiometabolic risk Integrate incretin mimetics in clinical practiceIntegrate incretin mimetics in clinical practice

Therapy for Type 2 Diabetes (T2DM): Sites of Action Pancreas LiverMuscles Gut Gut Thiazolidinedione Exogenous insulin Biguanides Incretin mimetics Amylin analogues Hyperglycemia Incretin mimetics Alpha glucosidase inhibitors Incretin mimetics Amylin analogues Sulfonylurea Secretagogues

Clearly, we have many choices in diabetes management, and yet...

master rheumatology series Master Rheumatology Series Inflammatory Cytokines in Rheumatoid Arthritis: Disease Modulators and Therapeutic Targets

Development of New Drugs Directed at Inflammatory Cytokines Dr White, MD master rheumatology series

masterrheumatology series Certolizumab: ACR Responses After 8 Weeks of Treatment Patients (%)

Managing the Strains of Influenza: An Effective Model for Prevention and Treatment

Structure of the Influenza Virus InfluenzaVirusAnatomy Neuraminidase Hemagglutinin Capsid ViralRNA M2Protein LipidEnvelope

Transmission and Reproduction of Influenza Virus Plasma membrane Endoplasmicreticulum Coated pit Cell receptor Extracellular Stage 1: Attachment Stage 2: Entry Stage 3: Uncoating Cytoplasm Budding Golgiapparatus mRNA (HA, NA) Synthesis of envelope proteins Nucleus

Influenza-like Illnesses Vaccine(n=576)Placebo(n=554)PVaccine(n=582)Placebo(n=596)P Illnesses NS <0.001 Days Ill <0001 Physician Visits NS <0.001 Lost Workdays Patients With Lost Workdays NS <0.001 Effectiveness of Vaccination in Healthy Working Adults